Effect of Additional Treatment With NMES After Achilles Tendon Rupture

Launched by VASTRA GOTALAND REGION · Aug 18, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment method called Neuromuscular Electrical Stimulation (NMES) for patients who have suffered an Achilles tendon rupture. The goal is to see how using this NMES device, which stimulates the calf muscles, can help improve recovery in the early stages after the injury. Researchers will look at various outcomes, such as how high patients can rise on their toes and whether their tendon length and jumping ability improve over time. The trial will include 70 participants, and they will be followed up at 3, 6, and 12 months after their injury to measure these outcomes.

To participate in this trial, individuals must have a fresh Achilles tendon rupture that was treated within two days of the injury. Key eligibility criteria include being between the ages of 18 and 75 and not having certain health conditions, such as diabetes or prior Achilles tendon injuries. Participants can expect to receive the NMES treatment and will be assessed on their recovery and physical capabilities. This research aims to provide new insights that could help tailor rehabilitation programs and support patients in returning to their previous levels of physical activity after an injury.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Achilles Tendon rupture
• • The injury should have been treated within two days from the trauma
• • The rupture is located in the mid portion of the tendon
• Exclusion Criteria:
• • Pregnancy
• • Having a pace maker, intra cardiac defibrillator or other active implant
• • Having had an Achilles Tendon rupture before, regardless of side
• • Having an earlier injury that will have an impact on lower leg function, regardless of side
• • Diabetes
• • Neuro vascular disease
• • Immunosuppressive treatment
• • Difficulties to understand the language or difficulties in understand instructions.
• • Unable to consent